Good morning, investor! We’re back at it again with another look at the biggest pre-market stock movers for Friday as the perfect way to close out the week. Earnings, clinical trials, and more have the markets moving today.
Let’s get right into those pre-market stock movers below!
Pre-Market Stock Movers: 10 Top Gainers
- Fuwei Films (NASDAQ:FFHL) stock is rocketing more than 76% higher today .
- Grove (NASDAQ:GRVI) shares are rising over 29% higher this morning .
- Property Solutions Acquisition (NASDAQ:PSAC) stock is soaring more than 16% .
- Nike (NYSE:NKE) shares are heading nearly 12% higher .
- Tonix Pharmaceuticals (NASDAQ:TNXP) stock is increasing over 11% .
- Torchlight Energy Resources (NASDAQ:TRCH) shares are getting a more than 8% boost as meme traders continue to rally the shares ahead of merger plans.
- Paysafe (NYSE:PSFE) stock is jumping over 7% .
- ENGlobal (NASDAQ:ENG) shares are climbing roughly 7% despite a lack of news this morning.
- Sio Gene Therapies (NASDAQ:SIOX) stock is recovering more than 6% after a fall yesterday.
- Hepion Pharmaceuticals (NASDAQ:HEPA) shares are up over 6% today.
10 Top Losers
- Marin Software (NASDAQ:MRIN) stock is retreating almost 14% after a strong rally yesterday.
- Theravance Biopharma (NASDAQ:TBPH) shares are falling more than 9% .
- Ring Energy (NYSEAMERICAN:REI) stock is dropping roughly 6% on no apparent news.
- Corbus Pharmaceuticals (NASDAQ:CRBP) shares are decreasing over 4% .
- Avinger (NASDAQ:AVGR) stock is pulling back more than 4% after rallying on Thursday.
- Aravive (NASDAQ:ARAV) shares are dipping over 4% .
- Digital Brands Group (NASDAQ:DBGI) stock is declining more than 4% after a rally yesterday.
- FedEx (NYSE:FDX) shares are heading 4% lower .
- Nxt-ID (NASDAQ:NXTD) stock was down over 3% this morning.
- Synchronoss Technologies (NASDAQ:SNCR) shares close out the pre-market stock movers list down more than 3% .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.